Is MASTER-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MASTER-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MASTER-F (THB46) is trading below our estimate of fair value (THB87.63)
Significantly Below Fair Value: MASTER-F is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MASTER-F?
Key metric: As MASTER-F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for MASTER-F. This is calculated by dividing MASTER-F's market cap by their current
earnings.
What is MASTER-F's PE Ratio?
PE Ratio
27.2x
Earnings
฿466.64m
Market Cap
฿12.67b
MASTER-F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue
6.2x
Enterprise Value/EBITDA
19.4x
PEG Ratio
1.5x
Price to Earnings Ratio vs Peers
How does MASTER-F's PE Ratio compare to its peers?
Price-To-Earnings vs Industry: MASTER-F is expensive based on its Price-To-Earnings Ratio (27.2x) compared to the TH Healthcare industry average (22x).
Price to Earnings Ratio vs Fair Ratio
What is MASTER-F's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
MASTER-F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
27.2x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MASTER-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.